Mazumdar Claire

CIK 00020346712 companiesBOSTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0002034671

Recent Transactions

28 trades

Sale
Bicara Therapeutics Inc.$BCAX
Common Stock
2026-03-09$19.17/sh−36,766→ 339,392 total
Exercise/Conversion
Bicara Therapeutics Inc.$BCAX
Common Stock
2026-03-09$3.79/sh+36,766→ 376,158 total
Exercise/Conversion
Bicara Therapeutics Inc.$BCAX
Stock Option (Right to Buy)
2026-03-09−36,766→ 191,107 total
Sale
Bicara Therapeutics Inc.$BCAX
Common Stock
2026-03-06$18.75/sh−3,817→ 339,392 total
Exercise/Conversion
Bicara Therapeutics Inc.$BCAX
Stock Option (Right to Buy)
2026-03-06−3,817→ 227,873 total
Exercise/Conversion
Bicara Therapeutics Inc.$BCAX
Common Stock
2026-03-06$3.79/sh+3,817→ 343,209 total
Exercise/Conversion
Bicara Therapeutics Inc.$BCAX
Stock Option (Right to Buy)
2026-03-05−1,786→ 231,690 total
Sale
Bicara Therapeutics Inc.$BCAX
Common Stock
2026-03-05$18.74/sh−1,786→ 339,392 total
Exercise/Conversion
Bicara Therapeutics Inc.$BCAX
Common Stock
2026-03-05$3.79/sh+1,786→ 341,178 total
Sale
Bicara Therapeutics Inc.$BCAX
Common Stock
2026-03-04$18.73/sh−2,631→ 339,392 total
Exercise/Conversion
Bicara Therapeutics Inc.$BCAX
Stock Option (Right to Buy)
2026-03-04−2,631→ 233,476 total
Exercise/Conversion
Bicara Therapeutics Inc.$BCAX
Common Stock
2026-03-04$3.79/sh+2,631→ 342,023 total
Award
Bicara Therapeutics Inc.$BCAX
Stock Option (Right to Buy)
2026-02-02+450,000→ 450,000 total
Exercise/Conversion
Bicara Therapeutics Inc.$BCAX
Common Stock
2025-12-16$5.45/sh+29,500→ 339,392 total
Exercise/Conversion
Bicara Therapeutics Inc.$BCAX
Stock Option (Right to Buy)
2025-12-16−29,500→ 565,512 total
Sale
Bicara Therapeutics Inc.$BCAX
Common Stock
2025-11-24$18.86/sh−41,163→ 309,892 total
Exercise/Conversion
Bicara Therapeutics Inc.$BCAX
Common Stock
2025-11-24$3.79/sh+41,163→ 351,055 total
Exercise/Conversion
Bicara Therapeutics Inc.$BCAX
Stock Option (Right to Buy)
2025-11-24−41,163→ 236,107 total
Exercise/Conversion
Bicara Therapeutics Inc.$BCAX
Stock Option (Right to Buy)
2025-10-16−24,103→ 277,270 total
Exercise/Conversion
Bicara Therapeutics Inc.$BCAX
Common Stock
2025-10-16$3.79/sh+24,103→ 333,995 total
Sale
Bicara Therapeutics Inc.$BCAX
Common Stock
2025-10-16$18.83/sh−24,103→ 309,892 total
Exercise/Conversion
Bicara Therapeutics Inc.$BCAX
Common Stock
2025-10-15$3.79/sh+13,289→ 323,181 total
Exercise/Conversion
Bicara Therapeutics Inc.$BCAX
Stock Option (Right to Buy)
2025-10-15−13,289→ 301,373 total
Sale
Bicara Therapeutics Inc.$BCAX
Common Stock
2025-10-15$18.84/sh−13,289→ 309,892 total
Sale
Bicara Therapeutics Inc.$BCAX
Common Stock
2025-10-13$18.92/sh−11,445→ 309,892 total
Exercise/Conversion
Bicara Therapeutics Inc.$BCAX
Stock Option (Right to Buy)
2025-10-13−11,445→ 314,662 total
Exercise/Conversion
Bicara Therapeutics Inc.$BCAX
Common Stock
2025-10-13$3.79/sh+11,445→ 321,337 total
Award
Relay Therapeutics, Inc.$RLAY
Stock Option (Right to Buy)
2025-06-09+421,241→ 421,241 total

Companies

Recent Filings

Address

BICARA THERAPEUTICS INC. 116 HUNTINGTON AVENUE, SUITE 703

BOSTON, MA, 02116

View on SEC.gov